India Digest: GSK Ventures eyes stake in 50 labs; Bessemer Ventures may back DocsApp

India Digest: GSK Ventures eyes stake in 50 labs; Bessemer Ventures may back DocsApp

A file photo of GSK Velu, who sold his 37% stake in Metropolis Healthcare to Carlyle Group two years ago. Photo: Hemant Mishra/Mint

GSK Ventures is looking to buy controlling stakes in around 50 pathology and diagnostic labs, while DocsApp is close to raising a $5.5m round led by Bessemer Venture.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter